Sequana Medical Investor Presentation 2021 Alfapump Ascites Treatment

Sequana Medical NV presents its innovative therapeutic solutions for treating diuretic-resistant fluid overload across liver disease, malignant ascites, and heart failure indications. The presentation covers the company's flagship alfapump® system and DSR® therapy in development, supported by clinical and pre-clinical research programs.